Abstract
Multi-modal radiomics to predict early treatment response from PSA (Prostate Specific Antigen) decline in prostate cancer patients under stereotactic body radiotherapy in MR-Linac.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have